Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details)

v3.21.1
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 12 Months Ended
Nov. 04, 2020
Sep. 24, 2020
Aug. 07, 2020
Aug. 06, 2020
Jul. 01, 2020
Jun. 30, 2020
Jun. 08, 2020
Apr. 29, 2020
Mar. 09, 2020
Jan. 14, 2020
Nov. 21, 2019
Sep. 20, 2019
Aug. 09, 2019
Sep. 24, 2020
Jul. 27, 2020
Feb. 25, 2020
Dec. 31, 2020
Dec. 31, 2019
Sep. 29, 2020
Stockholders' Equity (Textual)                                      
Number of authorized shares increased (in Shares)                             10,000,000        
Issued of common stock (in Shares)                   758,725                  
Common stock value                   $ 5,000,000             $ 5,000,000    
Common stock issued (in Shares)                                 9,678,840    
common stock value                                 $ 13,218,091    
Debt and accrued interest                                 $ 10,461,191    
Options granted (in Shares)                                 199,143    
Options granted exercise price (in Dollars per share)                                 $ 0.80 $ 1.67  
Stock based compensation                                 $ 1,158,173 $ 149,893  
Compensation issued                                 $ 5,141,989 247,720  
Restriction of common stock, description     the Company issued 94,471 shares of restricted common stock with a grant date value $205,000 to certain officers and directors. The restricted common stock remains subject to transfer and forfeiture restrictions until the shares vest on the one-year anniversary of the date of grant.                                
Warrants merger description                         Prior to the August 9, 2019 Closing Date of the Merger (see Note 1 – Background and Basis of Presentation), BRAC issued 14,305,000 five-year warrants (the “BRAC Warrants”) for the purchase of the Company’s common stock at $11.50 per share in connection with BRAC’s initial public offering. These previously issued BRAC Warrants are deemed to be issued in connection with the Merger, as a result of the reverse recapitalization. As of result of the August 9, 2019 Merger, the Company issued to the former owners of Allied Esports and WPT five-year warrants to purchase an aggregate of 3,800,003 shares of common stock at a price of $11.50 per share and issued five-year warrants for the purchase of an aggregate of 532,000 shares of common stock to the Noteholders with an exercise price of $11.50 per share.             
Warrants to purchase common stock (in Shares)             1,454,546                        
Price per warrant (in Dollars per share)             $ 4.13                        
Minimum [Member]                                      
Stockholders' Equity (Textual)                                      
Authorized shares of common stock (in Shares) 75,000,000                           65,000,000        
Maximum [Member]                                      
Stockholders' Equity (Textual)                                      
Authorized shares of common stock (in Shares) 100,000,000                           75,000,000        
Put Option Agreement [Member]                                      
Stockholders' Equity (Textual)                                      
Aggregate gross proceeds                               $ 2,000,000.0      
Purchase price of per option share (in Dollars per share)                               $ 1.963      
Put option expires period (in Shares)                 1,018,848                    
Put option purchase price of per share (in Dollars per share)                 $ 1.963                    
Total proceeds of option shares (in Shares)                 2,000,000                    
Gross proceeds                                     $ 21,875
Equity purchase option description                                 Prior to the Closing Date, BRAC sold an option to purchase up to 600,000 units, exercisable at $11.50 per Unit, in connection with BRAC’s initial public offering (the “Equity Purchase Option”). Each Unit consisted of one and one-tenth shares of common stock and a warrant to purchase one share of common stock at $11.50 per share. Effective upon the closing of the Merger, the units converted by their terms into the shares and warrants, and the option now represents the ability to buy such securities directly (and not units). The Equity Purchase Option may be exercised on either a cash or a cashless basis, at the holder’s option, and expires on October 4, 2022.    
Number of restricted shares of common stock issued (in Shares)         18,958                            
Equity Incentive Plan [Member]                                      
Stockholders' Equity (Textual)                                      
Common stock reserved under the plan (in Shares)                                 3,463,305    
Shares available for issuance (in Shares)                                 471,486    
Discontinued Operation [Member]                                      
Stockholders' Equity (Textual)                                      
Compensation issued                                 $ 40,165 6,986  
Convertible Debt [Member]                                      
Stockholders' Equity (Textual)                                      
Common stock value               $ 9,998,845                      
Common stock issued (in Shares)               3,392,857                      
Conversion of units               $ 5,000,000                      
Put Option Agreement [Member]                                      
Stockholders' Equity (Textual)                                      
Put option agreement, description                               a)The total number of shares that may be issued under the Agreement will be limited to 19.99% of the Company’s outstanding shares on the date the Agreement is signed (the “Exchange Cap”), unless stockholder approval is obtained to issue shares in excess of the Exchange Cap; b)The Company may not issue, and the Chairman may not purchase Option Shares to the extent that such issuance would result in the Chairman and his affiliates beneficially owning more than 19.99% of the then issued and outstanding shares of the Company’s common stock unless (i) such ownership would not be the largest ownership position in the Company, or (ii) stockholder approval is obtained for ownership in excess of 19.99%;  c)The Company may not issue, and the Chairman may not purchase any Option Shares if such issuance and purchase would be considered equity compensation under the rules of The Nasdaq Stock Market unless stockholder approval is obtained for such issuance; and  d)Option Shares are subject to a six-month lock-up period whereby they cannot be sold or transferred.       
Equity Option [Member]                                      
Stockholders' Equity (Textual)                                      
Options granted (in Shares)       120,000 80,000           2,080,000 400,000              
Options granted exercise price (in Dollars per share)       $ 2.17 $ 2.11           $ 4.09 $ 5.66              
Vesting period       4 years 4 years           4 years 4 years              
Vest date of grant       25.00% 25.00%           25.00% 25.00%              
Grant value       $ 97,947 $ 61,186           $ 3,263,551 $ 867,120              
Stock Options [Member]                                      
Stockholders' Equity (Textual)                                      
Vesting period                                 2 years 10 months 24 days    
Compensation issued                                 $ 214,239 22,339  
Unrecognized compensation expense                                 $ 1,884,569    
Restricted Stock [Member]                                      
Stockholders' Equity (Textual)                                      
Fair value at date of grant                           $ 50,000          
Aggregate of common stock, shares (in Shares)                       80,393              
Aggregate of common stock, value         $ 40,000                            
Vesting period                                 1 year    
Compensation issued                                 $ 588,220 $ 127,152  
Unrecognized compensation expense                                 239,779    
Number of restricted shares of common stock issued (in Shares)                           35,714          
Chief Financial Officer [Member]                                      
Stockholders' Equity (Textual)                                      
Option to purchase of common shares (in Shares)       50,000                              
Vested grant value       $ 109,000                              
Aggregate of common stock, shares (in Shares)     50,000                                
Aggregate of common stock, value     $ 109,000                                
Vesting period, description     The 50,000 shares of restricted common stock have transfer and forfeiture restrictions until the shares vest in two equal installments on August 18, 2021 and August 18, 2022.                                
Board of Directors Chairman [Member]                                      
Stockholders' Equity (Textual)                                      
Vested grant value   $ 20,000                                  
Common stock issued (in Shares)   14,286                                  
Officers and employees [Member]                                      
Stockholders' Equity (Textual)                                      
Common stock issued (in Shares)     217,999                                
Fair value at date of grant     $ 474,000                                
Board of Directors [Member]                                      
Stockholders' Equity (Textual)                                      
Aggregate of common stock, shares (in Shares)           20,000                          
Aggregate of common stock, value           $ 43,356           $ 455,000              
Stock based compensation                                 $ 8,386    
Transition Agreement [Member]                                      
Stockholders' Equity (Textual)                                      
Stock based compensation     64,093                                
Purchase of common stock, shares     $ 170,000                                
Grant date value of shares (in Shares)     266,733                                
Transition Agreement [Member] | Chief Financial Officer [Member]                                      
Stockholders' Equity (Textual)                                      
Stock based compensation     $ 50,000